Global Wound Care Biologics Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031

TABLE OF CONTENTS

1 Study Coverage

• 1.1 Wound Care Biologics Product Introduction
• 1.2 Market by Type
  • 1.2.1 Global Wound Care Biologics Market Size Growth Rate by Type (2020 VS 2024 VS 2031)
  • 1.2.2 Biologic Skin Substitutes
  • 1.2.3 Enzyme Based Formulations
  • 1.2.4 Growth Factors
• 1.3 Market by Application
  • 1.3.1 Global Wound Care Biologics Market Size Growth Rate by Application (2020 VS 2024 VS 2031)
  • 1.3.2 Acute Wounds
  • 1.3.3 Chronic Wounds
  • 1.3.4 Surgical Wounds
• 1.4 Assumptions and Limitations
• 1.5 Study Objectives
• 1.6 Years Considered

2 Executive Summary

• 2.1 Global Wound Care Biologics Market Size Estimates and Forecasts
• 2.2 Wound Care Biologics Market Size by Region: 2024 Versus 2031
  • 2.2.1 Global Wound Care Biologics Revenue by Region: 2020-2025
  • 2.2.2 Global Wound Care Biologics Revenue Forecast by Region (2026-2031)
  • 2.2.3 Global Wound Care Biologics Revenue Market Share by Region (2020-2031)

3 Market Segments

• 3.1 Breakdown Data by Type
  • 3.1.1 Global Wound Care Biologics Revenue by Type (2020-2031)
  • 3.1.2 Global Wound Care Biologics Revenue Market Share by Type (2020-2031)
• 3.2 Breakdown Data by Application
  • 3.2.1 Global Wound Care Biologics Revenue by Application (2020-2031)
  • 3.2.2 Global Wound Care Biologics Revenue Market Share by Application (2020-2031)
• 3.3 by Type and by Application Crossing Analysis
  • 3.3.1 Biologic Skin Substitutes of Wound Care Biologics Revenue Market Share by Application
  • 3.3.2 Enzyme Based Formulations of Wound Care Biologics Revenue Market Share by Application
  • 3.3.3 Growth Factors of Wound Care Biologics Revenue Market Share by Application

4 Global Wound Care Biologics by Company

• 4.1 Global Wound Care Biologics Revenue by Company (2020-2025)
• 4.2 Global Wound Care Biologics Revenue Share by Company (2020-2025)
• 4.3 Competitive Landscape
  • 4.3.1 Key Wound Care Biologics Companies around the World: Ranking by Revenue
  • 4.3.2 Global Wound Care Biologics Market Concentration Ratio (CR5 and HHI) & (2020-2025)
  • 4.3.3 Global Wound Care Biologics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
• 4.4 Global Wound Care Biologics Companies Headquarters & Product Type
  • 4.4.1 Global Wound Care Biologics Companies Headquarters
  • 4.4.2 Date of International Companies Enter into Wound Care Biologics Market
  • 4.4.3 Global Wound Care Biologics Companies Product & Service
  • 4.4.4 Biologic Skin Substitutes Revenue Market Share of Wound Care Biologics by Company
  • 4.4.5 Enzyme Based Formulations Revenue Market Share of Wound Care Biologics by Company
  • 4.4.6 Growth Factors Revenue Market Share of Wound Care Biologics by Company
• 4.5 Global Wound Care Biologics Mergers & Acquisitions, Expansion Plans

5 Company Profiles

• 5.1 Smith and Nephew
  • 5.1.1 Smith and Nephew Corporation Information
  • 5.1.2 Smith and Nephew Description, Business Overview
  • 5.1.3 Smith and Nephew Wound Care Biologics Products Offered
  • 5.1.4 Smith and Nephew Wound Care Biologics Revenue and Gross Margin (2020-2025)
  • 5.1.5 Smith and Nephew Wound Care Biologics Revenue by Product in 2024
  • 5.1.6 Smith and Nephew Wound Care Biologics Revenue by Application in 2024
  • 5.1.7 Smith and Nephew Wound Care Biologics Revenue by Geographic Area in 2024
  • 5.1.8 Smith and Nephew Recent Developments
• 5.2 Orthofix Medical
  • 5.2.1 Orthofix Medical Corporation Information
  • 5.2.2 Orthofix Medical Description, Business Overview
  • 5.2.3 Orthofix Medical Wound Care Biologics Products Offered
  • 5.2.4 Orthofix Medical Wound Care Biologics Revenue and Gross Margin (2020-2025)
  • 5.2.5 Orthofix Medical Wound Care Biologics Revenue by Product in 2024
  • 5.2.6 Orthofix Medical Wound Care Biologics Revenue by Application in 2024
  • 5.2.7 Orthofix Medical Wound Care Biologics Revenue by Geographic Area in 2024
  • 5.2.8 Orthofix Medical Recent Developments
• 5.3 Organogenesis
  • 5.3.1 Organogenesis Corporation Information
  • 5.3.2 Organogenesis Description, Business Overview
  • 5.3.3 Organogenesis Wound Care Biologics Products Offered
  • 5.3.4 Organogenesis Wound Care Biologics Revenue and Gross Margin (2020-2025)
  • 5.3.5 Organogenesis Wound Care Biologics Revenue by Product in 2024
  • 5.3.6 Organogenesis Wound Care Biologics Revenue by Application in 2024
  • 5.3.7 Organogenesis Wound Care Biologics Revenue by Geographic Area in 2024
  • 5.3.8 Organogenesis Recent Developments
• 5.4 MiMedx
  • 5.4.1 MiMedx Corporation Information
  • 5.4.2 MiMedx Description, Business Overview
  • 5.4.3 MiMedx Wound Care Biologics Products Offered
  • 5.4.4 MiMedx Wound Care Biologics Revenue and Gross Margin (2020-2025)
  • 5.4.5 MiMedx Wound Care Biologics Revenue by Product in 2024
  • 5.4.6 MiMedx Wound Care Biologics Revenue by Application in 2024
  • 5.4.7 MiMedx Wound Care Biologics Revenue by Geographic Area in 2024
  • 5.4.8 MiMedx Recent Developments
• 5.5 Integra
  • 5.5.1 Integra Corporation Information
  • 5.5.2 Integra Description, Business Overview
  • 5.5.3 Integra Wound Care Biologics Products Offered
  • 5.5.4 Integra Wound Care Biologics Revenue and Gross Margin (2020-2025)
  • 5.5.5 Integra Wound Care Biologics Revenue by Product in 2024
  • 5.5.6 Integra Wound Care Biologics Revenue by Application in 2024
  • 5.5.7 Integra Wound Care Biologics Revenue by Geographic Area in 2024
  • 5.5.8 Integra Recent Developments
• 5.6 Integra LifeSciences
  • 5.6.1 Integra LifeSciences Corporation Information
  • 5.6.2 Integra LifeSciences Description, Business Overview
  • 5.6.3 Integra LifeSciences Wound Care Biologics Products Offered
  • 5.6.4 Integra LifeSciences Wound Care Biologics Revenue and Gross Margin (2020-2025)
  • 5.6.5 Integra LifeSciences Wound Care Biologics Revenue by Product in 2024
  • 5.6.6 Integra LifeSciences Wound Care Biologics Revenue by Application in 2024
  • 5.6.7 Integra LifeSciences Wound Care Biologics Revenue by Geographic Area in 2024
  • 5.6.8 Integra LifeSciences Recent Developments
• 5.7 Celularity
  • 5.7.1 Celularity Corporation Information
  • 5.7.2 Celularity Description, Business Overview
  • 5.7.3 Celularity Wound Care Biologics Products Offered
  • 5.7.4 Celularity Wound Care Biologics Revenue and Gross Margin (2020-2025)
  • 5.7.5 Celularity Wound Care Biologics Revenue by Product in 2024
  • 5.7.6 Celularity Wound Care Biologics Revenue by Application in 2024
  • 5.7.7 Celularity Wound Care Biologics Revenue by Geographic Area in 2024
  • 5.7.8 Celularity Recent Developments
• 5.8 Amnio Technology, LLC
  • 5.8.1 Amnio Technology, LLC Corporation Information
  • 5.8.2 Amnio Technology, LLC Description, Business Overview
  • 5.8.3 Amnio Technology, LLC Wound Care Biologics Products Offered
  • 5.8.4 Amnio Technology, LLC Wound Care Biologics Revenue and Gross Margin (2020-2025)
  • 5.8.5 Amnio Technology, LLC Wound Care Biologics Revenue by Product in 2024
  • 5.8.6 Amnio Technology, LLC Wound Care Biologics Revenue by Application in 2024
  • 5.8.7 Amnio Technology, LLC Wound Care Biologics Revenue by Geographic Area in 2024
  • 5.8.8 Amnio Technology, LLC Recent Developments
• 5.9 Skye Biologics
  • 5.9.1 Skye Biologics Corporation Information
  • 5.9.2 Skye Biologics Description, Business Overview
  • 5.9.3 Skye Biologics Wound Care Biologics Products Offered
  • 5.9.4 Skye Biologics Wound Care Biologics Revenue and Gross Margin (2020-2025)
  • 5.9.5 Skye Biologics Wound Care Biologics Revenue by Product in 2024
  • 5.9.6 Skye Biologics Wound Care Biologics Revenue by Application in 2024
  • 5.9.7 Skye Biologics Wound Care Biologics Revenue by Geographic Area in 2024
  • 5.9.8 Skye Biologics Recent Developments
• 5.10 Pinnacle Transplant Technologies
  • 5.10.1 Pinnacle Transplant Technologies Corporation Information
  • 5.10.2 Pinnacle Transplant Technologies Description, Business Overview
  • 5.10.3 Pinnacle Transplant Technologies Wound Care Biologics Products Offered
  • 5.10.4 Pinnacle Transplant Technologies Wound Care Biologics Revenue and Gross Margin (2020-2025)
  • 5.10.5 Pinnacle Transplant Technologies Wound Care Biologics Revenue by Product in 2024
  • 5.10.6 Pinnacle Transplant Technologies Wound Care Biologics Revenue by Application in 2024
  • 5.10.7 Pinnacle Transplant Technologies Wound Care Biologics Revenue by Geographic Area in 2024
  • 5.10.8 Pinnacle Transplant Technologies Recent Developments
• 5.11 Convatec Group
  • 5.11.1 Convatec Group Corporation Information
  • 5.11.2 Convatec Group Description, Business Overview
  • 5.11.3 Convatec Group Wound Care Biologics Products Offered
  • 5.11.4 Convatec Group Wound Care Biologics Revenue and Gross Margin (2020-2025)
  • 5.11.5 Convatec Group Wound Care Biologics Revenue by Product in 2024
  • 5.11.6 Convatec Group Wound Care Biologics Revenue by Application in 2024
  • 5.11.7 Convatec Group Wound Care Biologics Revenue by Geographic Area in 2024
  • 5.11.8 Convatec Group Recent Developments
• 5.12 Stryker Corporation
  • 5.12.1 Stryker Corporation Corporation Information
  • 5.12.2 Stryker Corporation Description, Business Overview
  • 5.12.3 Stryker Corporation Wound Care Biologics Products Offered
  • 5.12.4 Stryker Corporation Wound Care Biologics Revenue and Gross Margin (2020-2025)
  • 5.12.5 Stryker Corporation Wound Care Biologics Revenue by Product in 2024
  • 5.12.6 Stryker Corporation Wound Care Biologics Revenue by Application in 2024
  • 5.12.7 Stryker Corporation Wound Care Biologics Revenue by Geographic Area in 2024
  • 5.12.8 Stryker Corporation Recent Developments
• 5.13 LifeNet Health
  • 5.13.1 LifeNet Health Corporation Information
  • 5.13.2 LifeNet Health Description, Business Overview
  • 5.13.3 LifeNet Health Wound Care Biologics Products Offered
  • 5.13.4 LifeNet Health Wound Care Biologics Revenue and Gross Margin (2020-2025)
  • 5.13.5 LifeNet Health Wound Care Biologics Revenue by Product in 2024
  • 5.13.6 LifeNet Health Wound Care Biologics Revenue by Application in 2024
  • 5.13.7 LifeNet Health Wound Care Biologics Revenue by Geographic Area in 2024
  • 5.13.8 LifeNet Health Recent Developments
• 5.14 Coloplast
  • 5.14.1 Coloplast Corporation Information
  • 5.14.2 Coloplast Description, Business Overview
  • 5.14.3 Coloplast Wound Care Biologics Products Offered
  • 5.14.4 Coloplast Wound Care Biologics Revenue and Gross Margin (2020-2025)
  • 5.14.5 Coloplast Wound Care Biologics Revenue by Product in 2024
  • 5.14.6 Coloplast Wound Care Biologics Revenue by Application in 2024
  • 5.14.7 Coloplast Wound Care Biologics Revenue by Geographic Area in 2024
  • 5.14.8 Coloplast Recent Developments
• 5.15 Tides Medical
  • 5.15.1 Tides Medical Corporation Information
  • 5.15.2 Tides Medical Description, Business Overview
  • 5.15.3 Tides Medical Wound Care Biologics Products Offered
  • 5.15.4 Tides Medical Wound Care Biologics Revenue and Gross Margin (2020-2025)
  • 5.15.5 Tides Medical Wound Care Biologics Revenue by Product in 2024
  • 5.15.6 Tides Medical Wound Care Biologics Revenue by Application in 2024
  • 5.15.7 Tides Medical Wound Care Biologics Revenue by Geographic Area in 2024
  • 5.15.8 Tides Medical Recent Developments
• 5.16 Imbed Biosciences
  • 5.16.1 Imbed Biosciences Corporation Information
  • 5.16.2 Imbed Biosciences Description, Business Overview
  • 5.16.3 Imbed Biosciences Wound Care Biologics Products Offered
  • 5.16.4 Imbed Biosciences Wound Care Biologics Revenue and Gross Margin (2020-2025)
  • 5.16.5 Imbed Biosciences Wound Care Biologics Revenue by Product in 2024
  • 5.16.6 Imbed Biosciences Wound Care Biologics Revenue by Application in 2024
  • 5.16.7 Imbed Biosciences Wound Care Biologics Revenue by Geographic Area in 2024
  • 5.16.8 Imbed Biosciences Recent Developments
• 5.17 NeXtGen Biologics
  • 5.17.1 NeXtGen Biologics Corporation Information
  • 5.17.2 NeXtGen Biologics Description, Business Overview
  • 5.17.3 NeXtGen Biologics Wound Care Biologics Products Offered
  • 5.17.4 NeXtGen Biologics Wound Care Biologics Revenue and Gross Margin (2020-2025)
  • 5.17.5 NeXtGen Biologics Wound Care Biologics Revenue by Product in 2024
  • 5.17.6 NeXtGen Biologics Wound Care Biologics Revenue by Application in 2024
  • 5.17.7 NeXtGen Biologics Wound Care Biologics Revenue by Geographic Area in 2024
  • 5.17.8 NeXtGen Biologics Recent Developments
• 5.18 Life Biologics
  • 5.18.1 Life Biologics Corporation Information
  • 5.18.2 Life Biologics Description, Business Overview
  • 5.18.3 Life Biologics Wound Care Biologics Products Offered
  • 5.18.4 Life Biologics Wound Care Biologics Revenue and Gross Margin (2020-2025)
  • 5.18.5 Life Biologics Wound Care Biologics Revenue by Product in 2024
  • 5.18.6 Life Biologics Wound Care Biologics Revenue by Application in 2024
  • 5.18.7 Life Biologics Wound Care Biologics Revenue by Geographic Area in 2024
  • 5.18.8 Life Biologics Recent Developments
• 5.19 Royal Biologics
  • 5.19.1 Royal Biologics Corporation Information
  • 5.19.2 Royal Biologics Description, Business Overview
  • 5.19.3 Royal Biologics Wound Care Biologics Products Offered
  • 5.19.4 Royal Biologics Wound Care Biologics Revenue and Gross Margin (2020-2025)
  • 5.19.5 Royal Biologics Wound Care Biologics Revenue by Product in 2024
  • 5.19.6 Royal Biologics Wound Care Biologics Revenue by Application in 2024
  • 5.19.7 Royal Biologics Wound Care Biologics Revenue by Geographic Area in 2024
  • 5.19.8 Royal Biologics Recent Developments
• 5.20 Merakris Therapeutics
  • 5.20.1 Merakris Therapeutics Corporation Information
  • 5.20.2 Merakris Therapeutics Description, Business Overview
  • 5.20.3 Merakris Therapeutics Wound Care Biologics Products Offered
  • 5.20.4 Merakris Therapeutics Wound Care Biologics Revenue and Gross Margin (2020-2025)
  • 5.20.5 Merakris Therapeutics Wound Care Biologics Revenue by Product in 2024
  • 5.20.6 Merakris Therapeutics Wound Care Biologics Revenue by Application in 2024
  • 5.20.7 Merakris Therapeutics Wound Care Biologics Revenue by Geographic Area in 2024
  • 5.20.8 Merakris Therapeutics Recent Developments
• 5.21 MediWound
  • 5.21.1 MediWound Corporation Information
  • 5.21.2 MediWound Description, Business Overview
  • 5.21.3 MediWound Wound Care Biologics Products Offered
  • 5.21.4 MediWound Wound Care Biologics Revenue and Gross Margin (2020-2025)
  • 5.21.5 MediWound Wound Care Biologics Revenue by Product in 2024
  • 5.21.6 MediWound Wound Care Biologics Revenue by Application in 2024
  • 5.21.7 MediWound Wound Care Biologics Revenue by Geographic Area in 2024
  • 5.21.8 MediWound Recent Developments

6 North America

• 6.1 North America Wound Care Biologics Market Size YoY Growth 2020-2031
• 6.2 North America Wound Care Biologics Market Facts & Figures by Country (2020-2031)
• 6.3 North America Wound Care Biologics Revenue by Type (2020-2025)
• 6.4 North America Wound Care Biologics Revenue by Application (2020-2025)

7 Asia-Pacific

• 7.1 Asia-Pacific Wound Care Biologics Market Size YoY Growth 2020-2031
• 7.2 Asia-Pacific Wound Care Biologics Market Facts & Figures by Region (2020-2031)
• 7.3 Asia-Pacific Wound Care Biologics Revenue by Type (2020-2025)
• 7.4 Asia-Pacific Wound Care Biologics Revenue by Application (2020-2025)

8 Europe

• 8.1 Europe Wound Care Biologics Market Size YoY Growth 2020-2031
• 8.2 Europe Wound Care Biologics Market Facts & Figures by Country (2020-2031)
• 8.3 Europe Wound Care Biologics Revenue by Type (2020-2025)
• 8.4 Europe Wound Care Biologics Revenue by Application (2020-2025)

9 Latin America

• 9.1 Latin America Wound Care Biologics Market Size YoY Growth 2020-2031
• 9.2 Latin America Wound Care Biologics Market Facts & Figures by Country (2020-2031)
• 9.3 Latin America Wound Care Biologics Revenue by Type (2020-2025)
• 9.4 Latin America Wound Care Biologics Revenue by Application (2020-2025)

10 Middle East and Africa

• 10.1 Latin America Wound Care Biologics Market Size YoY Growth 2020-2031
• 10.2 Middle East and Africa Wound Care Biologics Market Facts & Figures by Country (2020-2031)
• 10.3 Middle East and Africa Wound Care Biologics Revenue by Type (2020-2025)
• 10.4 Middle East and Africa Wound Care Biologics Revenue by Application (2020-2025)

11 Supply Chain and Sales Channel analysis

• 11.1 Wound Care Biologics Supply Chain Analysis
• 11.2 Wound Care Biologics Key Raw Materials and Upstream Suppliers
• 11.3 Wound Care Biologics Clients Analysis
• 11.4 Wound Care Biologics Sales Channel and Sales Model Analysis
  • 11.4.1 Wound Care Biologics Distribution Channel Analysis: Indirect Sales VS Direct Sales
  • 11.4.2 Wound Care Biologics Distribution Channel Analysis: Online Sales VS Offline Sales
  • 11.4.3 Wound Care Biologics Distributors

12 Wound Care Biologics Market Dynamics

• 12.1 Wound Care Biologics Industry Trends
• 12.2 Wound Care Biologics Market Drivers
• 12.3 Wound Care Biologics Market Challenges
• 12.4 Wound Care Biologics Market Restraints

13 Research Findings and Conclusion

14 Appendix

• 14.1 Research Methodology
  • 14.1.1 Methodology/Research Approach
    • 14.1.1.1 Research Programs/Design
    • 14.1.1.2 Market Size Estimation
    • 14.1.1.3 Market Breakdown and Data Triangulation
  • 14.1.2 Data Source
    • 14.1.2.1 Secondary Sources
    • 14.1.2.2 Primary Sources
• 14.2 Author Details
• 14.3 Disclaimer

List of Tables

Table 1. Global Wound Care Biologics Market Size Growth Rate (CAGR) by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Global Wound Care Biologics Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 3. Global Wound Care Biologics Market Size by Region (US$ Million): 2024 VS 2031

Table 4. Global Wound Care Biologics Revenue by Region (2020-2025) & (US$ Million)

Table 5. Global Wound Care Biologics Revenue Forecast by Region (2026-2031) & (US$ Million)

Table 6. Global Wound Care Biologics Revenue by Type (2020-2025) & (US$ Million)

Table 7. Global Wound Care Biologics Revenue Forecast by Type (2026-2031) & (US$ Million)

Table 8. Global Wound Care Biologics Revenue by Application (2020-2025) & (US$ Million)

Table 9. Global Wound Care Biologics Revenue Forecast by Application (2026-2031) & (US$ Million)

Table 10. Wound Care Biologics Revenue by Company (2020-2025) & (US$ Million)

Table 11. Wound Care Biologics Revenue Share by Company (2020-2025)

Table 12. Ranking of Global Top Wound Care Biologics Players by Revenue (US$ Million) in 2024

Table 13. Global Wound Care Biologics Companies Market Concentration Ratio (CR5 and HHI) & (2020-2025)

Table 14. Global Wound Care Biologics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Wound Care Biologics as of 2024)

Table 15. Global Wound Care Biologics Companies Headquarters

Table 16. Date of International Companies Enter into Wound Care Biologics Market

Table 17. Global Wound Care Biologics Companies Product & Service

Table 18. Global Wound Care Biologics Mergers & Acquisitions, Expansion Plans

Table 19. Smith and Nephew Corporation Information

Table 20. Smith and Nephew Description and Business Overview

Table 21. Smith and Nephew Wound Care Biologics Product

Table 22. Smith and Nephew Wound Care Biologics Revenue (US$ Million) and Gross Margin (2020-2025)

Table 23. Smith and Nephew Revenue Proportion of Wound Care Biologics by Product in 2024

Table 24. Smith and Nephew Revenue Proportion of Wound Care Biologics by Application in 2024

Table 25. Smith and Nephew Revenue Proportion of Wound Care Biologics by Geographic Area in 2024

Table 26. Smith and Nephew Recent Developments

Table 27. Orthofix Medical Corporation Information

Table 28. Orthofix Medical Description and Business Overview

Table 29. Orthofix Medical Wound Care Biologics Product

Table 30. Orthofix Medical Wound Care Biologics Revenue (US$ Million) and Gross Margin (2020-2025)

Table 31. Orthofix Medical Revenue Proportion of Wound Care Biologics by Product in 2024

Table 32. Orthofix Medical Revenue Proportion of Wound Care Biologics by Application in 2024

Table 33. Orthofix Medical Revenue Proportion of Wound Care Biologics by Geographic Area in 2024

Table 34. Orthofix Medical Recent Developments

Table 35. Organogenesis Corporation Information

Table 36. Organogenesis Description and Business Overview

Table 37. Organogenesis Wound Care Biologics Product

Table 38. Organogenesis Wound Care Biologics Revenue (US$ Million) and Gross Margin (2020-2025)

Table 39. Organogenesis Revenue Proportion of Wound Care Biologics by Product in 2024

Table 40. Organogenesis Revenue Proportion of Wound Care Biologics by Application in 2024

Table 41. Organogenesis Revenue Proportion of Wound Care Biologics by Geographic Area in 2024

Table 42. Organogenesis Recent Developments

Table 43. MiMedx Corporation Information

Table 44. MiMedx Description and Business Overview

Table 45. MiMedx Wound Care Biologics Product

Table 46. MiMedx Wound Care Biologics Revenue (US$ Million) and Gross Margin (2020-2025)

Table 47. MiMedx Revenue Proportion of Wound Care Biologics by Product in 2024

Table 48. MiMedx Revenue Proportion of Wound Care Biologics by Application in 2024

Table 49. MiMedx Revenue Proportion of Wound Care Biologics by Geographic Area in 2024

Table 50. MiMedx Recent Developments

Table 51. Integra Corporation Information

Table 52. Integra Description and Business Overview

Table 53. Integra Wound Care Biologics Product

Table 54. Integra Wound Care Biologics Revenue (US$ Million) and Gross Margin (2020-2025)

Table 55. Integra Revenue Proportion of Wound Care Biologics by Product in 2024

Table 56. Integra Revenue Proportion of Wound Care Biologics by Application in 2024

Table 57. Integra Revenue Proportion of Wound Care Biologics by Geographic Area in 2024

Table 58. Integra Recent Developments

Table 59. Integra LifeSciences Corporation Information

Table 60. Integra LifeSciences Description and Business Overview

Table 61. Integra LifeSciences Wound Care Biologics Product

Table 62. Integra LifeSciences Wound Care Biologics Revenue (US$ Million) and Gross Margin (2020-2025)

Table 63. Integra LifeSciences Revenue Proportion of Wound Care Biologics by Product in 2024

Table 64. Integra LifeSciences Revenue Proportion of Wound Care Biologics by Application in 2024

Table 65. Integra LifeSciences Revenue Proportion of Wound Care Biologics by Geographic Area in 2024

Table 66. Integra LifeSciences Recent Developments

Table 67. Celularity Corporation Information

Table 68. Celularity Description and Business Overview

Table 69. Celularity Wound Care Biologics Product

Table 70. Celularity Wound Care Biologics Revenue (US$ Million) and Gross Margin (2020-2025)

Table 71. Celularity Revenue Proportion of Wound Care Biologics by Product in 2024

Table 72. Celularity Revenue Proportion of Wound Care Biologics by Application in 2024

Table 73. Celularity Revenue Proportion of Wound Care Biologics by Geographic Area in 2024

Table 74. Celularity Recent Developments

Table 75. Amnio Technology, LLC Corporation Information

Table 76. Amnio Technology, LLC Description and Business Overview

Table 77. Amnio Technology, LLC Wound Care Biologics Product

Table 78. Amnio Technology, LLC Wound Care Biologics Revenue (US$ Million) and Gross Margin (2020-2025)

Table 79. Amnio Technology, LLC Revenue Proportion of Wound Care Biologics by Product in 2024

Table 80. Amnio Technology, LLC Revenue Proportion of Wound Care Biologics by Application in 2024

Table 81. Amnio Technology, LLC Revenue Proportion of Wound Care Biologics by Geographic Area in 2024

Table 82. Amnio Technology, LLC Recent Developments

Table 83. Skye Biologics Corporation Information

Table 84. Skye Biologics Description and Business Overview

Table 85. Skye Biologics Wound Care Biologics Product

Table 86. Skye Biologics Wound Care Biologics Revenue (US$ Million) and Gross Margin (2020-2025)

Table 87. Skye Biologics Revenue Proportion of Wound Care Biologics by Product in 2024

Table 88. Skye Biologics Revenue Proportion of Wound Care Biologics by Application in 2024

Table 89. Skye Biologics Revenue Proportion of Wound Care Biologics by Geographic Area in 2024

Table 90. Skye Biologics Recent Developments

Table 91. Pinnacle Transplant Technologies Corporation Information

Table 92. Pinnacle Transplant Technologies Description and Business Overview

Table 93. Pinnacle Transplant Technologies Wound Care Biologics Product

Table 94. Pinnacle Transplant Technologies Wound Care Biologics Revenue (US$ Million) and Gross Margin (2020-2025)

Table 95. Pinnacle Transplant Technologies Revenue Proportion of Wound Care Biologics by Product in 2024

Table 96. Pinnacle Transplant Technologies Revenue Proportion of Wound Care Biologics by Application in 2024

Table 97. Pinnacle Transplant Technologies Revenue Proportion of Wound Care Biologics by Geographic Area in 2024

Table 98. Pinnacle Transplant Technologies Recent Developments

Table 99. Convatec Group Corporation Information

Table 100. Convatec Group Description and Business Overview

Table 101. Convatec Group Wound Care Biologics Product

Table 102. Convatec Group Wound Care Biologics Revenue (US$ Million) and Gross Margin (2020-2025)

Table 103. Convatec Group Revenue Proportion of Wound Care Biologics by Product in 2024

Table 104. Convatec Group Revenue Proportion of Wound Care Biologics by Application in 2024

Table 105. Convatec Group Revenue Proportion of Wound Care Biologics by Geographic Area in 2024

Table 106. Convatec Group Recent Developments

Table 107. Stryker Corporation Corporation Information

Table 108. Stryker Corporation Description and Business Overview

Table 109. Stryker Corporation Wound Care Biologics Product

Table 110. Stryker Corporation Wound Care Biologics Revenue (US$ Million) and Gross Margin (2020-2025)

Table 111. Stryker Corporation Revenue Proportion of Wound Care Biologics by Product in 2024

Table 112. Stryker Corporation Revenue Proportion of Wound Care Biologics by Application in 2024

Table 113. Stryker Corporation Revenue Proportion of Wound Care Biologics by Geographic Area in 2024

Table 114. Stryker Corporation Recent Developments

Table 115. LifeNet Health Corporation Information

Table 116. LifeNet Health Description and Business Overview

Table 117. LifeNet Health Wound Care Biologics Product

Table 118. LifeNet Health Wound Care Biologics Revenue (US$ Million) and Gross Margin (2020-2025)

Table 119. LifeNet Health Revenue Proportion of Wound Care Biologics by Product in 2024

Table 120. LifeNet Health Revenue Proportion of Wound Care Biologics by Application in 2024

Table 121. LifeNet Health Revenue Proportion of Wound Care Biologics by Geographic Area in 2024

Table 122. LifeNet Health Recent Developments

Table 123. Coloplast Corporation Information

Table 124. Coloplast Description and Business Overview

Table 125. Coloplast Wound Care Biologics Product

Table 126. Coloplast Wound Care Biologics Revenue (US$ Million) and Gross Margin (2020-2025)

Table 127. Coloplast Revenue Proportion of Wound Care Biologics by Product in 2024

Table 128. Coloplast Revenue Proportion of Wound Care Biologics by Application in 2024

Table 129. Coloplast Revenue Proportion of Wound Care Biologics by Geographic Area in 2024

Table 130. Coloplast Recent Developments

Table 131. Tides Medical Corporation Information

Table 132. Tides Medical Description and Business Overview

Table 133. Tides Medical Wound Care Biologics Product

Table 134. Tides Medical Wound Care Biologics Revenue (US$ Million) and Gross Margin (2020-2025)

Table 135. Tides Medical Revenue Proportion of Wound Care Biologics by Product in 2024

Table 136. Tides Medical Revenue Proportion of Wound Care Biologics by Application in 2024

Table 137. Tides Medical Revenue Proportion of Wound Care Biologics by Geographic Area in 2024

Table 138. Tides Medical Recent Developments

Table 139. Imbed Biosciences Corporation Information

Table 140. Imbed Biosciences Description and Business Overview

Table 141. Imbed Biosciences Wound Care Biologics Product

Table 142. Imbed Biosciences Wound Care Biologics Revenue (US$ Million) and Gross Margin (2020-2025)

Table 143. Imbed Biosciences Revenue Proportion of Wound Care Biologics by Product in 2024

Table 144. Imbed Biosciences Revenue Proportion of Wound Care Biologics by Application in 2024

Table 145. Imbed Biosciences Revenue Proportion of Wound Care Biologics by Geographic Area in 2024

Table 146. Imbed Biosciences Recent Developments

Table 147. NeXtGen Biologics Corporation Information

Table 148. NeXtGen Biologics Description and Business Overview

Table 149. NeXtGen Biologics Wound Care Biologics Product

Table 150. NeXtGen Biologics Wound Care Biologics Revenue (US$ Million) and Gross Margin (2020-2025)

Table 151. NeXtGen Biologics Revenue Proportion of Wound Care Biologics by Product in 2024

Table 152. NeXtGen Biologics Revenue Proportion of Wound Care Biologics by Application in 2024

Table 153. NeXtGen Biologics Revenue Proportion of Wound Care Biologics by Geographic Area in 2024

Table 154. NeXtGen Biologics Recent Developments

Table 155. Life Biologics Corporation Information

Table 156. Life Biologics Description and Business Overview

Table 157. Life Biologics Wound Care Biologics Product

Table 158. Life Biologics Wound Care Biologics Revenue (US$ Million) and Gross Margin (2020-2025)

Table 159. Life Biologics Revenue Proportion of Wound Care Biologics by Product in 2024

Table 160. Life Biologics Revenue Proportion of Wound Care Biologics by Application in 2024

Table 161. Life Biologics Revenue Proportion of Wound Care Biologics by Geographic Area in 2024

Table 162. Life Biologics Recent Developments

Table 163. Royal Biologics Corporation Information

Table 164. Royal Biologics Description and Business Overview

Table 165. Royal Biologics Wound Care Biologics Product

Table 166. Royal Biologics Wound Care Biologics Revenue (US$ Million) and Gross Margin (2020-2025)

Table 167. Royal Biologics Revenue Proportion of Wound Care Biologics by Product in 2024

Table 168. Royal Biologics Revenue Proportion of Wound Care Biologics by Application in 2024

Table 169. Royal Biologics Revenue Proportion of Wound Care Biologics by Geographic Area in 2024

Table 170. Royal Biologics Recent Developments

Table 171. Merakris Therapeutics Corporation Information

Table 172. Merakris Therapeutics Description and Business Overview

Table 173. Merakris Therapeutics Wound Care Biologics Product

Table 174. Merakris Therapeutics Wound Care Biologics Revenue (US$ Million) and Gross Margin (2020-2025)

Table 175. Merakris Therapeutics Revenue Proportion of Wound Care Biologics by Product in 2024

Table 176. Merakris Therapeutics Revenue Proportion of Wound Care Biologics by Application in 2024

Table 177. Merakris Therapeutics Revenue Proportion of Wound Care Biologics by Geographic Area in 2024

Table 178. Merakris Therapeutics Recent Developments

Table 179. MediWound Corporation Information

Table 180. MediWound Description and Business Overview

Table 181. MediWound Wound Care Biologics Product

Table 182. MediWound Wound Care Biologics Revenue (US$ Million) and Gross Margin (2020-2025)

Table 183. MediWound Revenue Proportion of Wound Care Biologics by Product in 2024

Table 184. MediWound Revenue Proportion of Wound Care Biologics by Application in 2024

Table 185. MediWound Revenue Proportion of Wound Care Biologics by Geographic Area in 2024

Table 186. MediWound Recent Developments

Table 187. North America Wound Care Biologics Revenue by Country (2020-2025) & (US$ Million)

Table 188. North America Wound Care Biologics Revenue by Country (2026-2031) & (US$ Million)

Table 189. North America Wound Care Biologics Revenue by Type (2020-2025) & (US$ Million)

Table 190. North America Wound Care Biologics Revenue by Application (2020-2025) & (US$ Million)

Table 191. Asia-Pacific Wound Care Biologics Revenue by Region (2020-2025) & (US$ Million)

Table 192. Asia-Pacific Wound Care Biologics Revenue by Region (2026-2031) & (US$ Million)

Table 193. Asia-Pacific Wound Care Biologics Revenue by Type (2020-2025) & (US$ Million)

Table 194. Asia-Pacific Wound Care Biologics Revenue by Application (2020-2025) & (US$ Million)

Table 195. Europe Wound Care Biologics Revenue by Country (2020-2025) & (US$ Million)

Table 196. Europe Wound Care Biologics Revenue by Country (2026-2031) & (US$ Million)

Table 197. Europe Wound Care Biologics Revenue by Type (2020-2025) & (US$ Million)

Table 198. Europe Wound Care Biologics Revenue by Application (2020-2025) & (US$ Million)

Table 199. Latin America Wound Care Biologics Revenue by Country (2020-2025) & (US$ Million)

Table 200. Latin America Wound Care Biologics Revenue by Country (2026-2031) & (US$ Million)

Table 201. Latin America Wound Care Biologics Revenue by Type (2020-2025) & (US$ Million)

Table 202. Latin America Wound Care Biologics Revenue by Application (2020-2025) & (US$ Million)

Table 203. Middle East and Africa Wound Care Biologics Revenue by Country (2020-2025) & (US$ Million)

Table 204. Middle East and Africa Wound Care Biologics Revenue by Country (2026-2031) & (US$ Million)

Table 205. Middle East and Africa Wound Care Biologics Revenue by Type (2020-2025) & (US$ Million)

Table 206. Middle East and Africa Wound Care Biologics Revenue by Application (2020-2025) & (US$ Million)

Table 207. Wound Care Biologics Key Raw Materials, Industry Status and Trend

Table 208. Wound Care Biologics Key Raw Materials and Upstream Suppliers

Table 209. Wound Care Biologics Clients Status and Trend

Table 210. Wound Care Biologics Typical Clients

Table 211. Wound Care Biologics Distributors

Table 212. Wound Care Biologics Market Trends

Table 213. Wound Care Biologics Market Drivers

Table 214. Wound Care Biologics Market Challenges

Table 215. Wound Care Biologics Market Restraints

Table 216. Research Programs/Design for This Report

Table 217. Key Data Information from Secondary Sources

Table 218. Key Data Information from Primary Sources

List of Figures

Figure 1. Wound Care Biologics Product Picture

Figure 2. Global Wound Care Biologics Market Size by Type (US$ Million): 2020 VS 2024 VS 2031

Figure 3. Global Wound Care Biologics Revenue Market Share by Type in 2024 & 2031

Figure 4. Biologic Skin Substitutes Product Picture

Figure 5. Enzyme Based Formulations Product Picture

Figure 6. Growth Factors Product Picture

Figure 7. Global Wound Care Biologics Market Size by Application (US$ Million): 2020 VS 2024 VS 2031

Figure 8. Global Wound Care Biologics Revenue Market Share by Application in 2024 & 2031

Figure 9. Acute Wounds

Figure 10. Chronic Wounds

Figure 11. Surgical Wounds

Figure 12. Wound Care Biologics Report Years Considered

Figure 13. Global Wound Care Biologics Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 14. Global Wound Care Biologics Market Size (2020-2031) & (US$ Million)

Figure 15. Global Wound Care Biologics Market Size Market Share by Region: 2024 Versus 2031

Figure 16. Global Wound Care Biologics Revenue Market Share by Region (2020-2031)

Figure 17. Global Wound Care Biologics Revenue Market Share Forecast by Type (2020-2031)

Figure 18. Global Wound Care Biologics Revenue Market Share Forecast by Application (2020-2031)

Figure 19. Biologic Skin Substitutes of Wound Care Biologics Revenue Market Share by Application, 2024 VS 2031

Figure 20. Enzyme Based Formulations of Wound Care Biologics Revenue Market Share by Application, 2024 VS 2031

Figure 21. Growth Factors of Wound Care Biologics Revenue Market Share by Application, 2024 VS 2031

Figure 22. Wound Care Biologics Revenue Share by Company (2024)

Figure 23. Wound Care Biologics Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 24. Biologic Skin Substitutes Revenue Proportion by Company in 2024

Figure 25. Enzyme Based Formulations Revenue Proportion by Company in 2024

Figure 26. Growth Factors Revenue Proportion by Company in 2024

Figure 27. North America Wound Care Biologics Revenue 2020-2031 (US$ Million)

Figure 28. North America Wound Care Biologics Revenue Market Share by Type (2020-2025)

Figure 29. North America Wound Care Biologics Revenue Market Share by Application (2020-2025)

Figure 30. Asia-Pacific Wound Care Biologics Revenue 2020-2031 (US$ Million)

Figure 31. Asia-Pacific Wound Care Biologics Revenue Market Share by Region (2020-2031)

Figure 32. Asia-Pacific Wound Care Biologics Revenue Market Share by Type (2020-2025)

Figure 33. Asia-Pacific Wound Care Biologics Revenue Market Share by Application (2020-2025)

Figure 34. Europe Wound Care Biologics Revenue Growth Rate 2020-2031 (US$ Million)

Figure 35. Europe Wound Care Biologics Revenue Market Share by Country (2020-2031)

Figure 36. Europe Wound Care Biologics Revenue Market Share by Type (2020-2025)

Figure 37. Europe Wound Care Biologics Revenue Market Share by Application (2020-2025)

Figure 38. Latin America Wound Care Biologics Revenue Growth Rate 2020-2031 (US$ Million)

Figure 39. Latin America Wound Care Biologics Revenue Market Share by Country (2020-2031)

Figure 40. Latin America Wound Care Biologics Revenue Market Share by Type (2020-2025)

Figure 41. Latin America Wound Care Biologics Revenue Market Share by Application (2020-2025)

Figure 42. Middle East and Africa Wound Care Biologics Revenue Growth Rate 2020-2031 (US$ Million)

Figure 43. Middle East and Africa Wound Care Biologics Revenue Market Share by Country (2020-2031)

Figure 44. Middle East and Africa Wound Care Biologics Revenue Market Share by Type (2020-2025)

Figure 45. Middle East and Africa Wound Care Biologics Revenue Market Share by Application (2020-2025)

Figure 46. Wound Care Biologics Supply Chain (Upstream and Downstream Market)

Figure 47. Global Production Market Share of Wound Care Biologics Raw Materials by Region in 2024

Figure 48. Wound Care Biologics Distribution Channels

Figure 49. Global Wound Care Biologics Percentage 2020-2031: Indirect Sales VS Direct Sales

Figure 50. Global Wound Care Biologics Percentage 2020-2031: Online Sales VS Offline Sales

Figure 51. Bottom-up and Top-down Approaches for This Report

Figure 52. Data Triangulation

Figure 53. Key Executives Interviewed